Stockscreener 앱 받기
4.81
0.42%
0.02
시간 외 거래:
4.72
-0.09
-1.87%
Oramed Pharmaceuticals Inc 주식(ORMP)의 최신 뉴스
Oramed Pharmaceuticals Incorporated Actuals & Estimates (TRADEGATE:OJU1) - TradingView
Top Penny Stocks To Watch In August 2026 - simplywall.st
Oramed (ORMP) EPS and Revenue: Profit Per Share Surpasses Its Benchmark in the Latest Reading; Post-Earnings: The Stock Ends Up 4.60% on the DayDividend Earnings Report - Vinanet
Oramed Pharmaceuticals Inc (NASDAQ: ORMP) Share Price, ORMP Stock News, ORMP Share Price & Updates - Kalkine
Nano Dimension Appoints Nadav Kidron to Lead Capital Allocation Review - citybiz
Oramed CEO Joins Nano Dimension Board as Directors Weigh Capital Options - Stock Titan
MSN Money - MSN
ORMP Price Today: Oramed Pharmaceuticals Inc. Stock Price, Quote & Chart | MEXC - MEXC
Oramed Pharmaceuticals (NASDAQ:ORMP) Upgraded by Wall Street Zen to Buy Rating - MarketBeat
Aquamarine Financial (ORMP) discloses 6.04% Oramed ownership in 13G/A - Stock Titan
Oramed Pharmaceuticals (NASDAQ:ORMP) Releases Quarterly Earnings Results - marketbeat.com
Oramed Pharmaceuticals Inc expected to post earnings of 43 cents a shareEarnings Preview - TradingView
Oramed: Q2 Earnings Snapshot - marketscreener.com
ORAMED PHARMACEUTICALS INC. 2Q 2026: Revenue $0 Net income $78.16M, EPS $1.84— 10-Q Summary - TradingView
Oramed Pharmaceuticals (NASDAQ: ORMP) pivots to investment model with $116M profit - Stock Titan
Oramed Pharmaceuticals Inc (ORMP) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Oramed Pharmaceuticals (ORMP) Projected to Release Quarterly Earnings on Thursday - marketbeat.com
Oramed Pharmaceuticals (NASDAQ:ORMP) Share Price Crosses Above 200 Day Moving AverageWhat's Next? - MarketBeat
Oramed Pharmaceuticals (ORMP) Holds Steady at $4.33 as Range-Bound Trading PersistsRounding Bottom - vinanet.vn
ORMP | Oramed Pharmaceuticals Inc. Executive Compensation - Quiver Quantitative
ORMP Q2'26 Earnings: revenue estimate is 0 USD - TradingView
Oramed Pharmaceuticals announces annual shareholder meeting - Bitget
ORAMED PHARMACEUTICALS INC. SEC Filing (Aug 3, 2026) | ORMP ARS - Stock Titan
Oramed Pharmaceuticals Shows Modest Uptick, Testing Resistance at $4.33Rip Sell Trade - vinanet.vn
Oramed Pharmaceuticals Market Sentiment - Benzinga
Oramed Pharmaceuticals Inc (ORMP) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Oramed Pharmaceuticals Inc (ORMP) Cash Flow - TradingKey
Oramed Pharmaceuticals Inc (ORMP) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Oramed Pharmaceuticals Inc (ORMP) Balance Sheet - TradingKey
ORMP Q4 2025 Earnings: EPS Surges Past Estimates Despite Revenue Absence, Stock Declines 3.13%Earnings Forecast Report - dars.gov.et
ORMP|Oramed Pharmaceuticals Inc|Price:4.762|Chg%:+0.192 - TradingKey
Oramed Pharmaceuticals Inc. Revenue Breakdown – NASDAQ:ORMP - TradingView
TradingKey - TradingKey
Oramed Pharmaceuticals Inc (ORMP) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Oramed Pharmaceuticals Inc (OJU1.SG) stock price, news, quote and history - Yahoo Finance UK
Nano Dimension Ltd. (NASDAQ: NNDM) sees Oramed stake drop to 3.3% - Stock Titan
AlTi Global Leads Our Selection Of 3 Promising Penny Stocks - simplywall.st
Oramed Pharmaceuticals (ORMP) Posts Slight Uptick as Stock Consolidates Near Key SupportJurik MA - vinanet.vn
Oramed stock trades quietly as diabetes pill strategy pivots after FDA setback - Ad-hoc-news.de
Oramed Pharmaceuticals Q4 2025 Earnings: EPS Surprise Driven by Non-Operating Gains; Stock Slips Despite BeatLong-Term Guidance - vinanet.vn
Oramed Pharmaceuticals Inc. Net Worth (2026) - GuruFocus
Price to sales forward of Oramed Pharmaceuticals Inc. – NASDAQ:ORMP - TradingView
Enterprise value to EBIT forward of Oramed Pharmaceuticals Inc. – NASDAQ:ORMP - TradingView
Oramed Pharmaceuticals highlights oral drug platform as investors assess long-term prospects - Ad-hoc-news.de
Oramed Releases Letter to Shareholders, Highlighting Russell 2000/3000 Index Inclusion, Scilex Loan Repayment, Strategic Portfolio Appreciation, and a Strengthened Balance Sheet - AOL.com
Oramed Pharmaceuticals outlines its oral drug strategy as Nasdaq-listed biotech pursues long-term gr - Ad Hoc News
ORMP Q4 2025 Earnings: Positive EPS Surprise Despite Revenue Absence, Stock Falls 5.91%Analyst Drop Coverage - dars.gov.et
Price to earnings forward of Oramed Pharmaceuticals Inc. – NASDAQ:ORMP - TradingView
Price to book forward of Oramed Pharmaceuticals Inc. – NASDAQ:ORMP - TradingView
Oramed Pharmaceuticals stock holds its ground. Investors await the next company update. - ad-hoc-news.de
ORMP News | ORAMED PHARMACEUTICALS INC (NASDAQ:ORMP) - ChartMill
Insider Sell: Avraham Gabay Sells 73,360 Shares of Oramed Pharma - GuruFocus
Oramed Pharmaceuticals COO & Cbo Sold Shares Worth Over $611K - TradingView
Oramed (NASDAQ: ORMP) COO sells 137K shares after option exercise - Stock Titan
ORAMED (NASDAQ: ORMP) CFO executes pre-planned sale of 73,360 shares - Stock Titan
Oramed Pharmaceuticals Incorporated Financial Disclosures & SEC Filings - TradingView
Form 144 ORAMED PHARMACEUTICALS INC. For: 1 July By Investing.com - Investing.com South Africa
137,000 shares flagged for sale by Oramed (NASDAQ: ORMP) in Form 144 - Stock Titan
Oramed (NASDAQ: ORMP) Form 144 notes 93,360 RSU shares on 06/18/2026 - Stock Titan
Oramed Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144 - Moomoo
Oramed Pharm Updates Bylaws, Streamlining Shareholder Actions - TipRanks
Oramed (NASDAQ: ORMP) revises bylaws and restructures Scilex note obligations - Stock Titan
Oramed Pharmaceuticals Inc.(NasdaqCM: ORMP) added to Russell 2000 Index - marketscreener.com
Oramed Pharmaceuticals Inc.(NasdaqCM: ORMP) added to Russell 2000 Value Benchmark - marketscreener.com
BML Investment Holds 2.5% of Oramed (ORMP) in Amended 13G/A - Stock Titan
Oramed Pharmaceuticals Inc.(NasdaqCM: ORMP) added to Russell 3000E Index - marketscreener.com
1.21%
1.07%
자본화:
|
볼륨(24시간):